Composed of dedicated radiologists, pathologists, clinical trial investigators, neurosurgeons and neuro-oncologists, the Tumor Board at the Penn Brain Center meets weekly to consider new brain tumor cases, and current cases that present challenges.
The Tumor Board’s mission is to reach consensus, when possible, on approaches to treatment, improve outcomes and the standard of care for brain tumor patients at Penn Medicine. Penn’s Tumor Board acts as a source of consultation for clinicians, and as a conduit to innovative therapies and clinical trials for patients.
Providers, if you think your patient may be a candidate for neurosurgery at Penn Medicine, consult on our provider-only line: 877-937-PENN (7366)
Related links:
Why Are Brain Tumor Second Opinions Important? — the Penn Brain Tumor Center
How a Neuro-Oncology Nurse Navigator Supports Patients During Brain Tumor Treatment — The Penn Brain Tumor Center
Clinical Trials and Research at the Penn Brain Tumor Center
The Brain Tumor Center | Improving Outcomes for Brain Tumor Patients
Why Choose the Brain Tumor Program
Glioblastoma Immunotherapy Research at Penn Medicine, Including CART-EGFRvIII Therapy
Follow clinical updates from Penn on Twitter
Published
September 19, 2019
Created by
BROADCASTMED